Clover Health Investments, Corp. (CLOV) vs NewAmsterdam Pharma Company N.V. (NAMS)
A side-by-side comparison of Clover Health Investments, Corp. and NewAmsterdam Pharma Company N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLOV
Clover Health Investments, Corp.
$4.63HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
NAMS
NewAmsterdam Pharma Company N.V.
$21.52HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — CLOV vs NAMS
growth of $100 · dividends reinvested · last 6yCLOV -64.0% (-15.7%/yr)NAMS +114.9% (+13.6%/yr)NAMS compounded faster over this window
Log scale — wide-divergence pair
CLOV NAMS
CLOV vs NAMS: by the numbers
- •NAMS is the larger company ($2.52B vs $2.40B market cap).
- •Both run net losses; CLOV's is the smaller (-0.74% vs -3644.21% net margin).
Metrics side by side
Valuation
| Metric | CLOV | NAMS |
|---|---|---|
| Forward P/E | 82.62 | N/A |
| P/S ratio | 0.97 | 353.29 |
| P/B ratio | 6.38 | 3.98 |
| FCF yield | 3.09% | N/A |
Profitability
| Metric | CLOV | NAMS |
|---|---|---|
| Gross margin | 18.57% | 92.15% |
| Operating margin | -0.74% | -1002.90% |
| Net margin | -0.74% | -3644.21% |
| ROE | -4.88% | -41.10% |
| ROIC | -4.62% | -38.70% |
Growth (annualized)
| Metric | CLOV | NAMS |
|---|---|---|
| Revenue CAGR (5Y) | 21.18% | N/A |
| Total return CAGR (5Y) | -8.36% | 18.30% |
Frequently asked
- How have CLOV and NAMS total returns compared?
- Over the past 5 years, CLOV delivered -8.36% and NAMS delivered 18.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Clover Health Investments ROENewAmsterdam Pharma ROEClover Health Investments operating marginNewAmsterdam Pharma operating marginClover Health Investments revenue growthNewAmsterdam Pharma revenue growthClover Health Investments free cash flowNewAmsterdam Pharma free cash flow
Clover Health Investments & NewAmsterdam Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.